BIOG B — Biogaia AB Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual income statement for Biogaia AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	747	785	1,104	1,297	1,423
Cost of Revenue
Gross Profit	547	583	802	950	1,031
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	519	531	742	853	999
Operating Profit	228	254	361	443	423
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	228	253	448	469	448
Provision for Income Taxes
Net Income After Taxes	180	196	374	365	351
Minority Interest
Net Income Before Extraordinary Items
Net Income	180	196	374	365	351
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	180	196	374	365	351
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.01	2.08	3.74	3.65	3.9
Dividends per Share